|
|
H. pylori is the #1 cause of ulcers and a known carcinogen |
|
|
|
|
|
|
(1)
|
Test it.
|
|
No fasting, no need to stop taking PPIs or H2 blockers
|
|
|
(2)
|
Monitor it.
|
|
Know if therapy is working and help patients remain compliant |
|
|
(3)
|
Test again.
|
|
Collect a third sample and retest to make sure your patient's infection has been eliminated
|
|
|
|
|
|
|
|
|
|
|
|
Decision
|
to treat
|
|
starts with an
|
|
H. pylori test
|
|
|
|
|
|
|
|
|
Sincerely,
|
|
Mike Shaughnessy
Executive Vice President
President, Meridian Global Diagnostics
|
|
|
|
|
|
|
|
|
|
|
ACG=American College of Gastroenterology; AGA=American Gastroenterological Association.
|
|
References: 1. NIH National Cancer Institute. Helicobacter pylori and Cancer. Available at: www.cancer.gov/about-cancer/causes-prevention/ risk/infectious-agents/h-pylori-fact-sheet#q1. Accessed May 24, 2016. 2. Chey WD, Wong BCY, and the Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2007;102:1808-1825. 3. American Gastroenterological Association Medical Position Statement: Evaluation of Dyspepsia, Gastroenterology, 2005; 129:1756-1780.
|
|
If you would like to opt out of receiving further email promotional information from Meridian Bioscience, Inc., please click here.
|
|
If you have recently opted out, please keep in mind it can take up to 10 days for your name to be removed from the Meridian Bioscience, Inc. email list.
|
|
|
|
|
|
|
|
3471 River Hills Drive Cincinnati, OH 45244 |
|
©2016 Meridian Bioscience, Inc. April 2016 |
|
|
|
|
|
|
|
|